GT Biopharma Inc (GTBP)

[Rando3]

If you’re hoping they read out study results, I didn’t get any data that you couldn’t get by looking at the data online. However, I didn’t introduce myself as an investor and asked about the trike technology. The response was detailed and enthusiastic. These research doctors at U of M are top in their field and when they tell me that this is some of the most promising research happening right now, I take note. I never asked about GTBP (OXIS) at the time. So the biggest question remains, is GTBP going to be able to monetize this drug? That’s the bet on any investment I guess. I personally believe, both as an investor and a friend of people with cancer, it’s worth the bet.